Apixaban in Acute Coronary SyndromesKARTHIKEYAN, Ganesan; EIKELBOOM, John W.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 5, pp 285-290, issn 1755-5914, 6 p.Article

Management of patients with acute coronary syndromes: What is the clinical role of direct thrombin inhibitors?EIKELBOOM, John W; FRENCH, John.Drugs (Basel). 2002, Vol 62, Num 13, pp 1839-1852, issn 0012-6667, 14 p.Article

The CHADS₂ score for stroke risk stratification in atrial fibrillation -friend or foe?KARTHIKEYAN, Ganesan; EIKELBOOM, John W.Thrombosis and haemostasis. 2010, Vol 104, Num 1, pp 45-48, issn 0340-6245, 4 p.Article

CYP2C19 Genetic Testing Should Not Be Done in All Patients Treated With Clopidogrel Who Are Undergoing Percutaneous Coronary InterventionPARE, Guillaume; EIKELBOOM, John W.Circulation. Cardiovascular interventions. 2011, Vol 4, Num 5, pp 514-521, issn 1941-7640, 8 p.Article

Monitoring unfractionated heparin with the aPTT : Time for a fresh look : Laboratory methods in the haemostatic laboratoryEIKELBOOM, John W; HIRSH, Jack.Thrombosis and haemostasis. 2006, Vol 96, Num 5, pp 547-552, issn 0340-6245, 6 p.Article

New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplastyEIKELBOOM, John W; WEITZ, Jeffrey I.BMJ (Overseas and retired doctors ed.). 2011, Vol 342, Num 7790, pp 224-227, issn 1759-2151, 4 p.Article

Inherited thrombophilia and pregnancy associated venous thromboembolismLIM, Wendy; EIKELBOOM, John W; GINSBERG, Jeffrey S et al.BMJ. British medical journal (International ed.). 2007, Vol 334, Num 7607, pp 1318-1321, issn 0959-8146, 4 p.Article

Bleeding and management of bleedingEIKELBOOM, John W; HIRSH, Jack.European heart journal supplements. 2006, Vol 8G, issn 1520-765X, G38-G45Article

Management of antiphospholipid antibody syndrome : A systematic reviewLIM, Wendy; CROWTHER, Mark A; EIKELBOOM, John W et al.JAMA, the journal of the American Medical Association. 2006, Vol 295, Num 9, pp 1050-1057, issn 0098-7484, 8 p.Article

Folic acid-based multivitamin therapy to prevent stroke: The jury is still outHANKEY, Graeme J; EIKELBOOM, John W.Stroke (1970). 2004, Vol 35, Num 8, pp 1995-1998, issn 0039-2499, 4 p.Article

Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: A meta-analysis of randomized, controlled trialsQUINLAN, Daniel J; MCQUILLAN, Andrew; EIKELBOOM, John W et al.Annals of internal medicine. 2004, Vol 140, Num 3, pp 175-183, issn 0003-4819, 9 p.Article

Targeting the Unstable Plaque in Acute Coronary Syndromes : ACUTE CORONARY SYNDROMESTHOMPSON, Peter L; MARK NIDORF, S; EIKELBOOM, John et al.Clinical therapeutics. 2013, Vol 35, Num 8, pp 1099-1107, issn 0149-2918, 9 p.Article

Dabigatran Etexilate: A New Oral Thrombin InhibitorHANKEY, Graeme J; EIKELBOOM, John W.Circulation (New York, N.Y.). 2011, Vol 123, Num 13, pp 1436-1450, issn 0009-7322, 15 p.Article

Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention TrialsEIKELBOOM, John W; QUINLAN, Daniel J; O'DONNELL, Martin et al.Circulation (New York, N.Y.). 2009, Vol 120, Num 20, pp 2006-2011, issn 0009-7322, 6 p.Article

Effect of fondaparinux 2.5 mg once daily on mortality : a meta-analysis of phase III randomized trials of venous thromboembolism preventionEIKELBOOM, John W.European heart journal supplements. 2008, Vol 10, Num C, issn 1520-765X, C8-C13Article

Beyond unfractionated heparin and warfarin : Current and future advancesHIRSH, Jack; O'DONNELL, Martin; EIKELBOOM, John W et al.Circulation (New York, N.Y.). 2007, Vol 116, Num 5, pp 552-560, issn 0009-7322, 9 p.Article

Aspirin resistanceHANKEY, Graeme J; EIKELBOOM, John W.Lancet (British edition). 2006, Vol 367, Num 9510, pp 606-617, issn 0140-6736, 12 p.Article

Low molecular weight heparins and heparinoidsEIKELBOOM, John W; HANKEY, Graeme J.Medical journal of Australia. 2002, Vol 177, Num 7, pp 379-383, issn 0025-729XArticle

Adding aspirin to clopidogrel after TIA and ischemic stroke : Benefits do not match risksHANKEY, Graeme J; EIKELBOOM, John W.Neurology. 2005, Vol 64, Num 7, pp 1117-1121, issn 0028-3878, 5 p.Article

Cyclooxygenase-2 inhibitors: Are they really atherothrombotic, and if not, why not?HANKEY, Graeme J; EIKELBOOM, John W.Stroke (1970). 2003, Vol 34, Num 11, pp 2736-2740, issn 0039-2499, 5 p.Article

Recurrent palmar-plantar erythrodysaesthesia following high-dose cytarabine treatment for acute lymphoblastic leukemiaCRAWFORD, Julie H; EIKELBOOM, John W; MCQUILLAN, Andrew et al.European journal of haematology. 2002, Vol 69, Num 5-6, pp 315-317, issn 0902-4441, 3 p.Article

Update on Antithrombotic Therapy New AnticoagulantsEIKELBOOM, John W; WEITZ, Jeffrey I.Circulation (New York, N.Y.). 2010, Vol 121, Num 13, pp 1523-1532, issn 0009-7322, 10 p.Article

Antithrombotic treatment for peripheral arterial diseaseHACKAM, Daniel G; EIKELBOOM, John W.Heart (London 1996). 2007, Vol 93, Num 3, pp 303-308, issn 1355-6037, 6 p.Article

Homocysteine levels in patients with Stroke: Clinical relevance and therapeutic implicationsHANKEY, Graeme J; EIKELBOOM, John W.CNS drugs. 2001, Vol 15, Num 6, pp 437-443, issn 1172-7047Article

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention : A randomized controlled trialEIKELBOOM, John W; O'DONNELL, Martin.JAMA, the journal of the American Medical Association. 2007, Vol 297, Num 1, issn 0098-7484, 43-51,91-92 [11 p.]Article